N. MUTLU Et Al. , "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range," CANADIAN JOURNAL OF UROLOGY , vol.16, no.2, pp.4558-4567, 2009
MUTLU, N. Et Al. 2009. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. CANADIAN JOURNAL OF UROLOGY , vol.16, no.2 , 4558-4567.
MUTLU, N., Turkeri, L. N., YENCİLEK, F., Demir, A., & Emerk, K., (2009). Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. CANADIAN JOURNAL OF UROLOGY , vol.16, no.2, 4558-4567.
MUTLU, NİLGÜN Et Al. "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range," CANADIAN JOURNAL OF UROLOGY , vol.16, no.2, 4558-4567, 2009
MUTLU, NİLGÜN Et Al. "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range." CANADIAN JOURNAL OF UROLOGY , vol.16, no.2, pp.4558-4567, 2009
MUTLU, N. Et Al. (2009) . "Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range." CANADIAN JOURNAL OF UROLOGY , vol.16, no.2, pp.4558-4567.
@article{article, author={NİLGÜN MUTLU Et Al. }, title={Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range}, journal={CANADIAN JOURNAL OF UROLOGY}, year=2009, pages={4558-4567} }